{
    "Trade/Device Name(s)": [
        "epoc Glucose Test",
        "Blood Gas, Electrolyte And Metabolite Test Card",
        "EPOC Blood Analysis System"
    ],
    "Submitter Information": "Epocal Inc.",
    "510(k) Number": "K090109",
    "Predicate Device Reference 510(k) Number(s)": [
        "K001387"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA"
    ],
    "Summary Letter Date": "June 24, 2009",
    "Summary Letter Received Date": "June 17, 2009",
    "Submission Date": "May 21, 2009",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Arterial whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "Heparinized collection device",
        "Non-heparinized collection device"
    ],
    "Instrument(s)/Platform(s)": [
        "EPOC Reader",
        "EPOC Host (mobile computing device)"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose oxidase-based amperometric detection",
        "Electrochemical sensor array"
    ],
    "Methodologies": [
        "Electrochemical measurement"
    ],
    "Submission Type(s)": [
        "Test",
        "System",
        "Analyzer",
        "Reagent",
        "Consumable",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for epoc Glucose Test addition to EPOC Blood Analysis System using glucose oxidase-based amperometric detection for whole blood glucose measurement",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in arterial or venous whole blood by trained medical professionals in laboratory or point of care settings for diagnosis and treatment of carbohydrate metabolism disorders",
    "fda_folder": "Clinical Chemistry"
}